As industry, governments and academia increasingly rely on patent landscapes to map scientific and technological trends, an interdisciplinary workshop provides recommendations for developing consistent and transparent landscaping practices.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Mapping the Patent Landscape of Quantum Technologies: Patenting Trends, Innovation and Policy Implications
IIC - International Review of Intellectual Property and Competition Law Open Access 06 July 2022
-
Evidence of insufficient quality of reporting in patent landscapes in the life sciences
Nature Biotechnology Open Access 07 March 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
OECD. The OECD Innovation Strategy: Getting a Head Start on Tomorrow (OECD, Paris, 2010).
OECD. Collaborative Mechanisms for Intellectual Property Management (OECD, Paris, 2011).
Gold, E.R. & Baker, A.J. L. Inf. Sci. 22, 76–97 (2012).
Managing Knowledge in Synthetic Biology: The Creation of Tools for Stronger Intellectual Property Analysis, Edinburgh, UK, June 20–21, 2012.
Lee, S., Yoon, B., Lee, C. & Park, J. Technol. Forecast. Soc. Change 76, 769–786 (2009).
Breitzman, A.F. & Mogee, M.E. J. Inf. Sci. 28, 187–205 (2002).
United Kingdom Intellectual Property Office. Regenerative Medicine: The Patent Landscape in 2011 (Intellectual Property Office, Newport, 2011). http://www.ipo.gov.uk/informatic-regenmed.pdf
United Nations Environment Program. Final report: patents and clean energy: bridging the gap between evidence and policy, (UNEP, EPO, ICTSD, Munich, 2010). http://www.epo.org/news-issues/issues/clean-energy/study.html
Lenoir, T. & Herron, P. J. Biomed. Discov. Collab. 4, 8 (2009).
Bonino, D., Ciarmella, A. & Corno, F. World Pat. Inf. 32, 30–38 (2010).
Yang, Y.Y., Akers, L., Klose, T. & Yang, C.B. World Pat. Inf. 30, 280–293 (2008).
Bergman, K. & Graff, G.D. Nat. Biotechnol. 25, 419–424 (2007).
Huys, I., Berthels, N., Matthijs, G. & Van Overwalle, G. Nat. Biotechnol. 27, 903–909 (2009).
OECD. OECD Patent Statistics Manual (OECD, Paris, 2009).
Lanjouw, J.O. & Schankerman, M. Econ. J. 114, 441–465 (2004).
Trajtenberg, M. Rand J. Econ. 21, 172–187 (1990).
Hall, B.H., Jaffe, A. & Trajtenberg, M. Rand J. Econ. 36, 16–38 (2005).
Hall, B.H., Jaffe, A.B. & Trajtenberg, M. NBER Working Paper 8498 (2001).
Allison, J.R., Lemley, M.A. & Walker, J. Georgetown Law J. 99, 677–712 (2011).
Small, H., Sweeney, E. & Greenlee, E. Scientometrica 8, 321–340 (1985).
Bubela, T., Strotmann, A., Noble, R. & Morrison, S. Cell Stem Cell 7, 25–30 (2010).
Jensen, K. & Murray, F. Science 310, 239–240 (2005).
Holman, C.M. UMKC Law Rev. 80, 563–605 (2012).
Holman, C.M. Nat. Biotechnol. 30, 240–244 (2012).
Acknowledgements
We would like to thank the participants from industry, government agencies and academia at the Managing Knowledge in Synthetic Biology: The Creation of Tools for Stronger Intellectual Property Analysis workshop hosted by the Innogen Institute of the University of Edinburgh in 2012. The workshop was supported by VALGEN (Value Addition through Genomics) and GE3LS (Genomics and its Related Ethical, Environmental, Economic, Legal and Social Aspects), a project sponsored by the Government of Canada through Genome Canada, Genome Prairie and Genome Quebec, and the PhytoMetaSyn project funded by Genome Canada, Genome Alberta and Genome Quebec. We thank A. Baker, D. Lewensohn, M. Bieber and L. Dacks for administrative and research support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Bubela, T., Gold, E., Graff, G. et al. Patent landscaping for life sciences innovation: toward consistent and transparent practices. Nat Biotechnol 31, 202–206 (2013). https://doi.org/10.1038/nbt.2521
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2521
This article is cited by
-
Mapping the patent landscape of medical machine learning
Nature Biotechnology (2023)
-
European patent protection for medical uses of known products and drug repurposing
Nature Biotechnology (2022)
-
Mapping the Patent Landscape of Quantum Technologies: Patenting Trends, Innovation and Policy Implications
IIC - International Review of Intellectual Property and Competition Law (2022)
-
Mapping the European patent landscape for medical uses of known products
Nature Biotechnology (2021)
-
Cellulose technologies applied to biomedical purposes from the patentometric point of view
Cellulose (2020)